Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease.
暂无分享,去创建一个
Roxana Alexandridis | Laurent Essioux | Benoit Lehallier | Tony Wyss-Coray | T. Wyss-Coray | M. Britschgi | B. Lehallier | L. Essioux | T. Nikolcheva | J. Gayán | Javier Gayan | Tania Nikolcheva | Markus Britschgi | R. Alexandridis
[1] Hongyue Dai,et al. A candidate plasma protein classifier to identify Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[2] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[3] Sylvia Richardson,et al. Statistical Applications in Genetics and Molecular Biology Comparing the Characteristics of Gene Expression Profiles Derived by Univariate and Multivariate Classification Methods , 2011 .
[4] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[5] Viswanath Devanarayan,et al. Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease , 2013, Alzheimer disease and associated disorders.
[6] M. Britschgi,et al. Focused Plasma Proteomics for the Study of Brain Aging and Neurodegeneration , 2013 .
[7] Zengyou He,et al. Stable Feature Selection for Biomarker Discovery , 2010, Comput. Biol. Chem..
[8] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[9] C. Jack,et al. Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative , 2012, Alzheimer's & Dementia.
[10] D. Collins,et al. Scoring by nonlocal image patch estimator for early detection of Alzheimer's disease☆ , 2012, NeuroImage: Clinical.
[11] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[12] A. Mitchell,et al. Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.
[13] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[14] D. Rueckert,et al. Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease , 2011, PloS one.
[15] A. Fagan,et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. , 2006, The American journal of psychiatry.
[16] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[17] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[18] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[19] J. Cummings,et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[20] A. Fagan,et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease , 2015, Alzheimer's & Dementia.
[21] P. Trzepacz,et al. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia , 2013, Neurobiology of Aging.
[22] Anne-Laure Boulesteix,et al. Stability and aggregation of ranked gene lists , 2009, Briefings Bioinform..
[23] Magda Tsolaki,et al. Plasma proteins predict conversion to dementia from prodromal disease , 2014, Alzheimer's & Dementia.
[24] Nick C Fox,et al. Hippocampal atrophy rates in Alzheimer disease , 2009, Neurology.
[25] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[26] K. Blennow,et al. Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia. , 2013, Journal of Alzheimer's disease : JAD.
[27] Mark E. Schmidt,et al. The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[28] A Rostagno,et al. Apolipoprotein J (clusterin) and Alzheimer's disease , 2000, Microscopy research and technique.
[29] Apolipoprotein ε4-Allele as a Significant Risk Factor for Conversion from Mild Cognitive Impairment to Alzheimer’s disease: a Meta-analysis of Prospective Studies , 2013, Journal of Molecular Neuroscience.
[30] Dong Han,et al. Diagnostic accuracy of 18F‐FDG and 11C‐PIB‐PET for prediction of short‐term conversion to Alzheimer’s disease in subjects with mild cognitive impairment , 2012, International journal of clinical practice.
[31] Mark E. Schmidt,et al. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[32] K. Rufibach,et al. Modeling of Pathological Traits in Alzheimer's Disease Based on Systemic Extracellular Signaling Proteome* , 2011, Molecular & Cellular Proteomics.
[33] Martina Bocchetta,et al. Imaging markers for Alzheimer disease , 2013, Neurology.
[34] R. Tibshirani,et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.
[35] M. Jorge Cardoso,et al. Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment☆ , 2013, NeuroImage: Clinical.
[36] G. Tripsianis,et al. Mild cognitive impairment: effect of education on the verbal and nonverbal tasks performance decline , 2012, Brain and behavior.
[37] F. LaFerla,et al. Alzheimer's disease. , 2010, The New England journal of medicine.
[38] D. A. Bennett,et al. Natural history of mild cognitive impairment in older persons , 2002, Neurology.
[39] Walter J Koroshetz,et al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. , 2012, Archives of neurology.
[40] F. Petraglia,et al. Dementia of the Alzheimer type and hypothalamus‐pituitary‐adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels , 1990, Acta neurologica Scandinavica.
[41] R. Katzman.,et al. Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.
[42] D. Shen,et al. Prediction of Alzheimer's Disease and Mild Cognitive Impairment Using Cortical Morphological Patterns Chong-yaw Wee, Pew-thian Yap, and Dinggang Shen; for the Alzheimer's Disease Neuroimaging Initiative , 2022 .
[43] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[44] R. Mahley,et al. Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases , 2014, Neurobiology of Disease.
[45] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[46] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[47] J. Yesavage,et al. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .
[48] K. Blennow,et al. Cerebrospinal fluid biomarkers for Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[49] Jian Lei. [Change of serum ACTH and cortisol levels in Alzheimer disease and mild cognition impairment]. , 2010, Zhonghua yi xue za zhi.
[50] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[51] A. Fagan,et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. , 2009, Archives of neurology.
[52] Burkhard Becher,et al. Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.
[53] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[54] C. Jack,et al. MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.
[55] Vladimir Fonov,et al. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning , 2013, NeuroImage.
[56] P. Sachdev,et al. Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals , 2012, PloS one.
[57] J. Trojanowski,et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.
[58] Keith A. Johnson,et al. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.
[59] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[60] G. Coppola. The OMICs : applications in neuroscience , 2013 .
[61] W. Klunk. Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia , 2011, Neurobiology of Aging.
[62] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[63] Eric Westman,et al. Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria , 2014, Front. Aging Neurosci..
[64] Verena D. Schmittmann,et al. Qgraph: Network visualizations of relationships in psychometric data , 2012 .
[65] T. Kurosaki,et al. Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.
[66] R. Killiany,et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.
[67] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[68] Chengjie Xiong,et al. Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis , 2011, PloS one.
[69] T. L. Brink,et al. Clinical Gerontology: A Guide to Assessment and Intervention , 1986 .
[70] Nick C Fox,et al. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .